Your browser doesn't support javascript.
loading
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.
Carras, Sylvain; Chartoire, Dimitri; Mareschal, Sylvain; Heiblig, Maël; Marçais, Antoine; Robinot, Rémy; Urb, Mirjam; Pommier, Roxane M; Julia, Edith; Chebel, Amel; Verney, Aurélie; Bertheau, Charlotte; Bardel, Emilie; Fezelot, Caroline; Courtois, Lucien; Lours, Camille; Bouska, Alyssa; Sharma, Sunandini; Lefebvre, Christine; Rouault, Jean-Pierre; Sibon, David; Ferrari, Anthony; Iqbal, Javeed; de Leval, Laurence; Gaulard, Philippe; Traverse-Glehen, Alexandra; Sujobert, Pierre; Blery, Mathieu; Salles, Gilles; Walzer, Thierry; Bachy, Emmanuel; Genestier, Laurent.
Afiliação
  • Carras S; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Chartoire D; Hospices Civils de Lyon, Lyon, France.
  • Mareschal S; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Heiblig M; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Marçais A; Hospices Civils de Lyon, Lyon, France.
  • Robinot R; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Urb M; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Pommier RM; Hospices Civils de Lyon, Lyon, France.
  • Julia E; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Chebel A; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Verney A; Hospices Civils de Lyon, Lyon, France.
  • Bertheau C; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Bardel E; Department of Hematology, Hospices Civils de Lyon, Lyon, France.
  • Fezelot C; INSERM U1111, CNRS UMR 5308, Centre International de Recherche en Infectiologie, Lyon, France.
  • Courtois L; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Lours C; Hospices Civils de Lyon, Lyon, France.
  • Bouska A; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Sharma S; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Lefebvre C; Hospices Civils de Lyon, Lyon, France.
  • Rouault JP; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Sibon D; Synergie Lyon Cancer, Plateforme de Bioinformatique "Gilles Thomas" Centre Léon Bérard, Lyon, France.
  • Ferrari A; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Iqbal J; Hospices Civils de Lyon, Lyon, France.
  • de Leval L; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Gaulard P; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Traverse-Glehen A; Hospices Civils de Lyon, Lyon, France.
  • Sujobert P; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Blery M; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
  • Salles G; Hospices Civils de Lyon, Lyon, France.
  • Walzer T; Centre de Recherche en Cancérologie de Lyon - Equipe Labellisée La Ligue 2017, INSERM U1052, Centre National de Recherche Scientifique (CNRS) UMR 5286, Université de Lyon, Centre Léon Bérard, Lyon, France.
  • Bachy E; Department of Pathology, Hospices Civils de Lyon, Lyon, France.
  • Genestier L; UR LIB, Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon I, Lyon, France.
J Clin Invest ; 131(13)2021 07 01.
Article em En | MEDLINE | ID: mdl-34043588
ABSTRACT
Peripheral T cell lymphomas (PTCLs) represent a significant unmet medical need with dismal clinical outcomes. The T cell receptor (TCR) is emerging as a key driver of T lymphocyte transformation. However, the role of chronic TCR activation in lymphomagenesis and in lymphoma cell survival is still poorly understood. Using a mouse model, we report that chronic TCR stimulation drove T cell lymphomagenesis, whereas TCR signaling did not contribute to PTCL survival. The combination of kinome, transcriptome, and epigenome analyses of mouse PTCLs revealed a NK cell-like reprogramming of PTCL cells with expression of NK receptors (NKRs) and downstream signaling molecules such as Tyrobp and SYK. Activating NKRs were functional in PTCLs and dependent on SYK activity. In vivo blockade of NKR signaling prolonged mouse survival, demonstrating the addiction of PTCLs to NKRs and downstream SYK/mTOR activity for their survival. We studied a large collection of human primary samples and identified several PTCLs recapitulating the phenotype described in this model by their expression of SYK and the NKR, suggesting a similar mechanism of lymphomagenesis and establishing a rationale for clinical studies targeting such molecules.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfoma de Células T Periférico / Receptores de Células Matadoras Naturais Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfoma de Células T Periférico / Receptores de Células Matadoras Naturais Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article